Tumor budding as a prognostic marker in laryngeal carcinoma

Pathology Research and Practice

Volumn 206, Issue 2, 2010, Pages 88-92

  Sarioglu, Sulen ^a   Acara, Cagdas ^a   Akman, Fadime Can ^a   Dag, Nihal ^a   Ecevit, Cenk ^a   Ikiz, Ahmet Omer ^a   Cetinayak, Oguz H ^a   Ada, Emel ^a  

^a DOKUZ EYLUL UNIVERSITY   (Turkey)

Author keywords

Budding; Distant metastasis; Laryngeal carcinoma; Prognosis

Indexed keywords

CISPLATIN;

ADULT; AGED; ARTICLE; CANCER RADIOTHERAPY; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DISTANT METASTASIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LARYNGECTOMY; LARYNX CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NECK DISSECTION; OVERALL SURVIVAL; PROGNOSIS; TUMOR GROWTH;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA; DISEASE-FREE SURVIVAL; HUMANS; KAPLAN-MEIERS ESTIMATE; LARYNGEAL NEOPLASMS; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PROGNOSIS;

EID: 74449083452     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2009.09.006     Document Type: Article

References (22)

1. Akman F.C., Dag N., Ataman O.U., Ecevit C., Ikiz A.O., Arslan I., Sari{dotless}oglu S., Ada E., and Kinay M. The impact of treatment center on the outcome of patients with laryngeal cancer treated with surgery and radiotherapy. Eur. Arch. Otorhinolaryngol. 265 (2008) 1245-1255
2. Choi H.J., Park K.J., Shin J.S., Roh M.S., Kwon H.C., and Lee H.S. Tumor budding as a prognostic marker in stage-III rectal carcinoma. Int. J. Colorectal Dis. 22 (2007) 863-868
3. Gabbert H. Mechanisms of tumor invasion: evidence from in vivo observations. Cancer Metastasis Rev. 4 (1985) 293-309
4. Gosens M.J., van Kempen L.C., van de Velde C.J., van Krieken J.H., and Nagtegaal I.D. Loss of membranous Ep-CAM in budding colorectal carcinoma cells. Mod. Pathol. 20 (2007) 221-232
5. Guzińska-Ustymowicz K. MMP-9 and cathepsin B expression in tumor budding as an indicator of a more aggressive phenotype of colorectal cancer (CRC). Anticancer Res. 26 (2006) 1589-1594
6. Hase K., Shatney C., Johnson D., Trollope M., and Vierra M. Prognostic value of tumor ''budding'' in patients with colorectal cancer. Dis. Colon Rectum 36 (1993) 627-635
7. Kanazawa H., Mitomi H., Nishiyama Y., Kishimoto I., Fukui N., and Nakamura Watanabe. Tumour budding at invasive margins and outcome in colorectal cancer. Colorectal Dis. 10 (2007) 41-47
8. Koike M., Kodera Y., Itoh Y., Nakayama G., Fujiwara M., Hamajima N., and Nakao A. Multivariate analysis of the pathologic features of esophageal squamous cell cancer: tumor budding is a significant independent prognostic factor. Ann. Surg. Oncol. 15 (2008) 1977-1982
9. Moriya Y., Niki T., Yamada T., Matsuno Y., Kondo H., and Hirohashi S. Increased expression of laminin-5 and its prognostic significance in lung adenocarcinomas of small size. Cancer 91 (2001) 1129-1141
10. Morodomi T., Isomoto H., Shirouzu K., Kakegawa K., Irie K., and Morimatsu M. An index for estimating the probability of lymph node metastasis in rectal cancers. Lymph node metastasis and the histopathology of actively invasive regions of cancer. Cancer 63 (1989) 539-543
11. Nilsson P.J., Rubio C., Lenander C., Auer G., and Glimelius B. Tumour budding detected by laminin-5 {gamma} 2-chain immunohistochemistry is of prognostic value in epidermoid anal cancer. Ann. Oncol. 16 (2005) 893-898
12. Oosterkamp S., de Jong J.M., Van den Ende P.L., Manni J.J., Dehing-Oberije C., and Kremer B. Predictive value of lymph node metastases and extracapsular extension for the risk of distant metastases in laryngeal carcinoma. Laryngoscope 116 (2006) 2067-2070
13. Ozdek A., Sarac S., Akyol M.U., Unal O.F., and Sungur A. Histopathological predictors of occult lymph node metastases in supraglottic squamous cell carcinomas. Eur. Arch. Otorhinolaryngol. 257 (2000) 389-392
14. Roh M.S., Lee J.I., and Choi P.J. Tumor budding as a useful prognostic marker in esophageal squamous cell carcinoma. Dis. Esophagus. 17 (2004) 333-337
15. Sarioglu S., Ozer E., Kirimca F., Sis B., and Pabuçcuoǧlu U. Matrix metalloproteinase-2 expression in laryngeal preneoplastic and neoplastic lesions. Pathol. Res. Pract. 197 (2001) 483-486
16. Sohn D.K., Chang H.J., Park J.W., Choi D.H., Han K.S., Hong C.W., Jung K.H., Kim D.Y., Lim S.B., Choi H.S., and Jeong S.Y. Histopathological risk factors for lymph node metastasis in submucosal invasive colorectal carcinoma of pedunculated or semipedunculated type. J. Clin. Pathol. 60 (2007) 912-915
17. Tadahiko M., Matsuoka H., Sugiyama M., Abe N., Sakamoto A., and Atomi Y. Actual number of tumor budding as a new tool for the individualization of treatment of T1 colorectal carcinomas. J. Gastroenterol. Hepatol. 21 (2006) 1115-1121
18. Thompson L.D., Wenig B.M., Heffner D.K., and Gnepp D.R. Exophytic and papillary squamous cell carcinomas of the larynx: a clinicopathologic series of 104 cases. Otolaryngol. Head Neck Surg. 120 (1999) 718-724
19. Ueno H., Jones A.M., Wilkinson K.H., Jass J.R., and Talbot I.C. Histological categorisation of fibrotic cancer stroma in advanced rectal cancer. Gut 53 (2004) 581-586
20. Ueno H., Murphy J., Jass J.R., Mochizuki H., and Talbot I.C. Tumour 'budding' as an index to estimate the potential of aggressiveness in rectal cancer. Histopathology 40 (2002) 127-132
21. Ueno H., Mochizuki H., Shinto E., Hashiguchi Y., Hase K., and Talbot I.C. Histological indices in biopsy specimens for estimating the probability of extended local spread in rectal cancer. Cancer 94 (2002) 2882-2891
22. Xie M., Sun Y., and Li Y. Expression of matrix metalloproteinases in supraglottic carcinoma and its clinical implication for estimating lymph node metastases. Laryngoscope 114 (2004) 2243-2248